Chemotherapy-Associated Toxicity in a Large Cohort of Elderly Patients with Non-small Cell Lung Cancer
Authors:
Open Access
- 1 January 2010
- journal article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 5 (1) , 90-98
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Treatment outcome in performance status 2 advanced NSCLC patients administered platinum-based combination chemotherapyLung Cancer, 2008
- Randomized cross-over study of patient preference for oral or intravenous vinorelbine in combination with carboplatin in the treatment of advanced NSCLCLung Cancer, 2008
- Randomized Phase III Trial Comparing Bexarotene (L1069-49)/Cisplatin/Vinorelbine With Cisplatin/Vinorelbine in Chemotherapy-Naïve Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer: SPIRIT IJournal of Clinical Oncology, 2008
- Treatment of Non-small Cell Lung Cancer, Stage IVChest, 2007
- Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: An Individual Patient Data Meta-analysisJNCI: Journal of the National Cancer Institute, 2007
- Assessment of functional status, symptoms and comorbidity in elderly patients with advanced non-small-cell lung cancer (NSCLC) treated with gemcitabine and vinorelbineClinical and Translational Oncology, 2007
- Variation in modes of chemotherapy administration for breast carcinoma and association with hospitalization for chemotherapy‐related toxicityCancer, 2005
- Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung CancerNew England Journal of Medicine, 2005
- Chemotherapeutic Management of Stage IV Non-small Cell Lung Cancer*Chest, 2003
- Information on Radiation Treatment in Patients with Breast CancerJournal of Clinical Epidemiology, 1999